XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 175,013 $ 150,021
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 15,395 17,422
Deferred tax expense 5,945 2,635
Loss on debt extinguishment 22,107 0
Net realized investment (gains) losses 1,505 (2,215)
Change in certain assets and liabilities:    
Accrued investment income 1,502 (1,130)
Reinsurance recoverable on loss reserves 2,188 (7,859)
Reinsurance recoverable on paid losses 36,072 63
Premium receivable (798) 937
Deferred insurance policy acquisition costs 133 (774)
Profit commission receivable 6,779 (5,430)
Loss reserves (32,250) 32,573
Unearned premiums (12,575) (13,546)
Return premium accrual (900) 2,900
Current income taxes 38,445 36,897
Other, net (30,550) (14,461)
Net cash provided by (used in) operating activities 228,011 198,033
Cash flows from investing activities:    
Purchases of investments (94,017) (652,328)
Proceeds from sales of investments 218,373 59,378
Proceeds from maturity of fixed income securities 225,972 318,892
Additions to property and equipment (888) (441)
Net cash provided by (used in) investing activities 349,440 (274,499)
Cash flows from financing activities:    
Purchase of convertible junior subordinated debentures (56,965) 0
Repayment of FHLB Advance (155,000) 0
Cash portion of loss on debt extinguishment (22,107) 0
Repurchase of common stock (123,640) 0
Dividends paid (26,112) (20,827)
Payment of withholding taxes related to share-based compensation net share settlement (8,688) (6,621)
Net cash provided by (used in) financing activities (392,512) (27,448)
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents 184,939 (103,914)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 304,958 296,680
Cash and cash equivalents and restricted cash and cash equivalents at end of period $ 489,897 $ 192,766